Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.
暂无分享,去创建一个
H. Lepor | D. Makarov | S. Loeb | N. Byrne | D. Walter | D. Wise | D. Becker | Binhuan Wang
[1] H. Lepor,et al. Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015 , 2018, JAMA.
[2] David C. Miller,et al. Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement , 2017, JAMA surgery.
[3] P. Stattin,et al. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden , 2017, JAMA oncology.
[4] C. Gross,et al. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. , 2016, Urology.
[5] Ronald C. Chen,et al. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Cooperberg,et al. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. , 2015, JAMA.
[7] John T. Wei,et al. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. , 2014, The Journal of urology.